Progression of kidney disease in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin versus usual care: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Progression of kidney disease in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin versus usual care: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Am J Kidney Dis. 2008 Sep; 52(3):412-24.

View in: PubMed

subject areas

Aged
Anticholesteremic Agents
Cholesterol
Disease Progression
Female
Glomerular Filtration Rate
Humans
Hypercholesterolemia
Hypertension
Incidence
Kidney Diseases
Kidney Failure, Chronic
Male
Middle Aged
Pravastatin
Treatment Outcome

authors with profiles

Jan N. Basile